InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Bridger Gary. Director active across 1 company, notably X4 Pharmaceuticals, Inc. Cumulatively, 3 reports have been logged. Activity tracked since 6 June 2022. The latest transaction was disclosed on 10 June 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations